EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway

Alaka Lamsal, Katrine Mørk Paulsen, Maria Juul Diekmann, Olav Hungnes, Kristian Alfsnes iD, Else Quist-Paulsen, Daniel Ruzek iD, Jiri Salat iD, Petra Strakova iD, Karen Angeliki Krogfelt iD, Arnulf Soleng, Rose Vikse iD und 1 weitere

Viruses · 2025

DOI: 10.3390/v17030291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Alaka Lamsal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, 0456 Oslo, Norway. Hauptthemen laut MEDLINE: Encephalitis, Tick-Borne, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TBFVnet, EU Interreg V-A, EU Interreg V-A program Scandtick Innovation project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tick-borne encephalitis virus (TBEV) is an emerging pathogen that initially causes flu-like symptoms and can progress to central nervous system (CNS) infections. Tick-borne encephalitis (TBE) is an endemic disease in southern coastal counties with regular human cases, while the causative agent, TBEV, is prevalent in ticks in most of the coastal regions of Norway. This study was aimed to understand TBEV infection status across Norway including both TBE endemic and non-endemic areas. For this, we analyzed a total of 1940 residual serum samples from 19 counties of Norway (as of 2016). The samples were initially screened by ELISA, followed by virus neutralization tests for TBEV confirmation. We found a similar TBEV seroprevalence of 1.7% in TBE endemic and 1.6% in non-endemic areas. Since TBE cases are only reported from endemic regions, our findings suggest a potential subclinical or asymptomatic infection and underdiagnosis in non-endemic areas. Notably, only 43% of the ELISA-positive samples were confirmed by virus neutralization tests indicating that not all ELISA positives are true TBEV infections. Additionally, 137 samples of patients presenting with symptoms of CNS infections from a non-endemic area were included. Of these samples, 11 ELISA-positive samples were analyzed for cross-reactivity among flaviviruses. Cross-reactivity was detected with Dengue virus, West Nile Virus, and non-specific reactions. This underscores the importance of using multiple diagnostic tests to confirm TBEV infections. None of the patients with CNS infection was found to be TBE positive, and in the whole cohort, we found a low TBEV seroprevalence of 0.7%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, Tick-BorneAntibodies, ViralRetrospective StudiesNorwayEncephalitis Viruses, Tick-BorneSeroepidemiologic StudiesCross ReactionsNeutralization TestsHumansFemaleEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle Aged

Stichwörter der Autor:innen

NorwayTBEV prevalencecentral nervous system infectionsseroprevalence studytick-borne encephalitis virus

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Virology, Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, 0456 Oslo, Norway.
  • Department of Natural Sciences and Environmental Health, Faculty of Technology, Natural Sciences and Maritime Sciences, University of South-Eastern Norway, Campus Bø, 3800 Bø, Norway.
  • Department of Bacteriology, Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, 0456 Oslo, Norway.
  • Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic.
  • Veterinary Research Institute, 601 77 Brno, Czech Republic.

ORCID-Profile: Kristian Alfsnes, Daniel Ruzek, Jiri Salat, Petra Strakova, Karen Angeliki Krogfelt, Rose Vikse, Åshild K Andreassen

Förderung

  • TBFVnet
  • EU Interreg V-A
  • EU Interreg V-A program Scandtick Innovation project
  • University of Southeastern Norway

Zitieren

APA

Lamsal, A., Paulsen, K. M., Diekmann, M. J., Hungnes, O., Alfsnes, K., Quist-Paulsen, E., Ruzek, D., Salat, J., Strakova, P., Krogfelt, K. A., Soleng, A., Vikse, R., & Andreassen, Å. K. (2025). A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway. Viruses. https://doi.org/10.3390/v17030291

Vancouver

Lamsal A, Paulsen KM, Diekmann MJ, Hungnes O, Alfsnes K, Quist-Paulsen E, et al. A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway. Viruses. 2025. doi:10.3390/v17030291

BibTeX
@article{Lamsal2025,
  author = {Lamsal, Alaka and Paulsen, Katrine Mørk and Diekmann, Maria Juul and Hungnes, Olav and Alfsnes, Kristian and Quist-Paulsen, Else and Ruzek, Daniel and Salat, Jiri and Strakova, Petra and Krogfelt, Karen Angeliki and Soleng, Arnulf and Vikse, Rose and Andreassen, Åshild K},
  title = {A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17030291}
}
Kostenlos starten →